Enkurin and uses thereof
AssigneeUniversity of Massachusetts
InventorsHarvey Florman, Melissa Jungnickel, Keith Sutton
Life of this patent
Estimating the term…
Abstract
A novel protein, enkurin, that is preferentially expressed in sperm has been discovered. Enkurin binds to TRPCs including TRPC2-S, a protein encoded by TRPC2 that is not predicted to be a calcium channel subunit. The invention includes methods of identifying compounds that affect enkurin expression or activity, and are useful, e.g., for contraception and treatment of infertility.
Claims75
A method of identifying a candidate compound that modulates the expression or activity of an enkurin polypeptide, the method comprising
- (a) obtaining a test sample comprising a cell that can express an enkurin polypeptide;
- (b) contacting the test sample with a test compound;
- (c) determining a level of expression or activity of the enkurin polypeptide in the test sample of (b);
- wherein the test compound is a candidate compound for modulating enkurin expression or activity if the level of expression or activity in the test sample contacted with the test compound is different from a predetermined value.
A method of diagnosing a disorder associated with aberrant expression of an enkurin polypeptide, the method comprising measuring enkurin polypeptide expression in a biological sample, wherein increased or decreased enkurin polypeptide expression in the biological sample compared to a control indicates a disorder associated with aberrant expression of an enkurin polypeptide.
A method of inhibiting fertility, the method comprising administering to a subject in need thereof an effective amount of a compound that decreases enkurin activity.
A method of increasing fertility, the method comprising administering to a male subject in need thereof, an effective amount of enkurin polypeptide.
A method for detecting an enkurin polypeptide in a biological sample, the method comprising:
- (a) contacting the biological sample with an antibody that specifically binds an enkurin polypeptide under conditions that allow the formation of an enkurin polypeptide-antibody complex;
- and
- (b) detecting any antibody-polypeptide complexes;
- wherein the presence of a complex indicates the presence of an enkurin polypeptide in the sample.
A pharmaceutical composition comprising an enkurin-modulating compound.
An isolated nucleic acid, the nucleotide sequence of which consists of SEQ ID NO:12 or a complement thereof.
An isolated nucleic acid comprising a sequence that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:1 or 2, or of a fragment of SEQ ID NO:1 or 2, wherein the polypeptide binds to a TRPC polypeptide.
A vector comprising the nucleotide sequence of SEQ ID NO:12, 20, 21, 23, 25, 27, 29, 31, 33, or 38 or a complement thereof.
A purified polypeptide encoded by the nucleotide sequence of SEQ ID NO:12 or 20.
An purified polypeptide consisting of the sequence of SEQ ID NO:1 or 2.
An antisense oligonucleotide that inhibits expression of enkurin protein encoded by SEQ ID NO:12, 20 or fragment thererof, or a nucleic acid sequence encoding the amino acid sequence of SEQ ID NO:9 or 10 or fragment thereof.
An antisense oligonucleotide that inhibits expression of a protein comprising the sequence of SEQ ID NO:1 or 2 or fragment thererof or the nucleic acid encoding the amino acid sequence of SEQ ID NO:9 or 10.
A purified antibody that binds specifically to the polypeptide having the amino acid sequence of SEQ ID NO:1 or 2 or a functional fragment thereof.
An isolated nucleic acid, the nucleotide sequence of which consists of SEQ ID NO:21 or a complement thereof.
An isolated nucleic acid comprising a sequence that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:22, 24, 30, 26, 28, 32, 38 or of a fragment thereof.
A vector comprising the nucleotide sequence of SEQ ID NO:21 or 33 or a complement thereof.
A purified polypeptide encoded by the nucleotide sequence of SEQ ID NO:21 or 33.
An purified polypeptide consisting of the sequence of SEQ ID NO:22, 24, 26, 28, 30, or 32.
An antisense oligonucleotide that inhibits expression of 5′ extended TRPC2 protein encoded by SEQ ID NO:29, 30, 38, or 39, or fragment thereof.
An antisense oligonucleotide that inhibits expression of a protein comprising the sequence of SEQ ID NO:22, 24, 26, 28, 30, or 32.
A purified antibody that binds specifically to the polypeptide having the amino acid sequence of SEQ ID NO:
- 22, 24, 26, 28, 30, or 32 or a functional fragment thereof.
A method of modulating an acrosome reaction (AR) of a sperm, the method comprising contacting the sperm with a compound that modulates the expression or activity of an enkurin polypeptide or a TRPC2-S polypeptide in an amount sufficient to inhibit or to activate the AR.
A method of promoting fertilization by stimulating the acrosome reaction, the method comprising the step of contacting a sperm with an effective amount of a compound that modulates the expression or activity or an enkurin or of a TRPC2-S.
A method of inhibiting the acrosome reaction, the method comprising the step of contacting a sperm with an effective amount of a compound that modulates the expression or activity of an enkurin, 5′ extended TRPC2 or splice variant thereof, or TRPC2-S or splice variant thereof.
A method of identifying a candidate compound that modulates the expression or activity of a 5′ extended TRPC2 polypeptide or splice variant thereof, the method comprising
- (a) obtaining a test sample comprising a cell that can express a 5′ extended TRPC2 polypeptide or a polypeptide of a splice variant thereof;
- (b) contacting the test sample with a test compound;
- (c) determining a level of expression or activity of the 5′ extended TRPC2 polypeptide or the polypeptide of a splice variant thereof in the test sample of (b);
- wherein the test compound is a candidate compound for modulating 5′ extended TRPC2 polypeptide or the polypeptide of a splice variant thereof, expression or activity if the level of expression or activity in the test sample contacted with the test compound is different from a predetermined value.
Dependencies are inferred from the claim text.